gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)GlobeNewsWire • 07/25/23
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLCGlobeNewsWire • 07/13/23
TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments ProjectGlobeNewsWire • 06/27/23
electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLCGlobeNewsWire • 06/14/23
electroCore Announces Poster to be Presented at the American Headache Society's 65th Annual Scientific MeetingGlobeNewsWire • 06/13/23
electroCore, Inc. Announces Departure of JP Errico from the Board of DirectorsGlobeNewsWire • 05/26/23
National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use DisordersGlobeNewsWire • 04/26/23
electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in JapanGlobeNewsWire • 04/11/23
electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South AfricaGlobeNewsWire • 04/06/23
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature BankGlobeNewsWire • 03/14/23
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific MeetingGlobeNewsWire • 03/13/23